Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Lung Cancer Clinical Trial
Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program
Status: Enrolling
Updated: 1/30/2018
UofL/Brown Cancer Center - Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Philippe Bedard Clinic Toronto
mi
from
Toronto,
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas Southwestern Simmons Comprehensive Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study Comparing the Combination of Nivolumab and Ipilimumab Versus Placebo in Participants With Localized Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Evansville, IN
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study Comparing the Combination of Nivolumab and Ipilimumab Versus Placebo in Participants With Localized Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridan Health System-Jersey Shore Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
HER2-positive Breast Cancer Clinical Trial
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The University of Kansas Cancer Center, North Clinic
mi
from
Kansas City, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
North Valley Breast Clinic
mi
from
Redding, CA
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Edinburgh Cancer Research UK Centre
mi
from
Edinburgh,
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Cancer Affiliates - Ocala
mi
from
Ocala, FL
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California
mi
from
Orange, CA
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
SCRI - Florida
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Institut Jules Bordet
mi
from
Brussel,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
New Mexico Cancer Care Alliance - Southwest Gynecology Oncology
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Maryland Greenebaum Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Chevy Chase Health Care Center/ RCCA
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Sarah Cannon Research Institute - Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Cancer Center
mi
from
Joplin, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
HCA Midwest Health
mi
from
Kansas City, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Oklahoma Cancer Specialists and Research Institute, LLC
mi
from
Tulsa, OK
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Intraoperative Detection of Residual Cancer in Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Beaumont Royal Oak
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
U3-1402 in Metastatic or Unresectable EGFR-mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Sarah Cannon Research Institute/Tennesse Oncology
mi
from
Nashville, TN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging
Status: Enrolling, Phase II, III
Updated: 12/31/1969
UR Medicine Breast Imaging
mi
from
Rochester, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Icon Cancer Care Wesley
mi
from
Auchenflower,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology (West 38) - USOR
mi
from
Austin, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Florida Cancer Specialists North
mi
from
Brandon, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers (Colorado Springs) - USOR
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncology - Dickson
mi
from
Dickson, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers (Lone Tree) - USOR
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncology Nashville
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncology - St Thomas West
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncology - Southern Hills
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers (Parker) - USOR
mi
from
Parker, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Compassionate Care Research Group Inc. at Compassionate Cancer Care Medical Group, Inc.
mi
from
Riverside, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Oncology Associates (Wilmont HOPE) - USOR
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology (Tyler) - USOR
mi
from
Tyler, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology & Hematology Associates Of Southwest Virginia, Inc.
mi
from
Wytheville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling, Phase
Updated: 12/31/1969
St. John's Hospital
mi
from
Maplewood, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling, Phase
Updated: 12/31/1969
North Memorial Health Care
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Institut Jules Bordet
mi
from
Brussel,
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Associates in Oncology & Hematology
mi
from
Bethesda, MD
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI - Tennessee Oncology
mi
from
Overland Park, KS
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Specialists - North Region
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Status: Enrolling, Phase II
Updated: 12/31/1969
Chris O'Brien Lifehouse
mi
from
Camperdown,
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Oncology Clinical Trial
KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Duke Cancer Center, Duke Uniersity
mi
from
Durham, NC
Click here to add this to my saved trials
Cancer Clinical Trial
A Study of APX3330 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 2/7/2018
START Midwest
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Our Lady of the Lake Physicians Group - Medical Oncology
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Mills-Peninsula Medical Center
mi
from
Burlingame, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Caro Cancer Center
mi
from
Caro, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Care Specialists of Illinois - Decatur
mi
from
Decatur, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Trinity Regional Medical Center
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Palo Alto Medical Foundation-Fremont
mi
from
Fremont, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
OptumCare Cancer Care at Seven Hills
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-POB II
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
University Cancer Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
OptumCare Cancer Care at MountainView
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Clinic
mi
from
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Ontario
mi
from
Ontario, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Care of Nevada-Pahrump
mi
from
Pahrump, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Lake Huron Medical Center
mi
from
Port Huron, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Rochester Hills
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at Christian Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser San Rafael-Gallinas
mi
from
San Rafael, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Macomb Hematology Oncology PC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Ann Arbor
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Genesis Healthcare System Cancer Care Center
mi
from
Zanesville, OH
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Aultman Alliance Cancer Center
mi
from
Alliance, OH
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Wellmont Medical Associates Oncology and Hematology
mi
from
Bristol, VA
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
AHN Cancer Institute at Jefferson
mi
from
Jefferson Hills, PA
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Norton Cancer Institute-Downtown
mi
from
Louisville, KY
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Southwest Virginia Regional Cancer Center
mi
from
Norton, VA
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Care Specialists of Central Illinois-Swansea
mi
from
Swansea, IL
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Lycera Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer
Status: Enrolling, Phase I
Updated: 1/10/2018
Shanghai Proton and Heavy Ion Center
mi
from
Shanghai,
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2 Study of Combination Immunotherapy and mRNA Vaccine in Subjects With NSCLC
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge (Consent only)
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Monmouth (Consent only)
mi
from
Middletown, NJ
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Hospital Sisters Health System (HSHS) St. Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Small-Cell Lung Cancer Clinical Trial
Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Texas Oncology-McKinney
mi
from
McKinney, TX
Click here to add this to my saved trials
Colon Cancer Clinical Trial
Fiber to Reduce Colon Cancer in Alaska Native People
Status: Enrolling
Updated: 12/31/1969
Alaskan Native Tribal Health Consortium
mi
from
Anchorage, AK
Click here to add this to my saved trials
Solid Tumor Clinical Trial
QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Chan Soon-Shiong Institute for Medicine
mi
from
El Segundo, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Local Consolidation Therapy (LCT) After Nivolumab and Ipilimumab (LONESTAR)
Status: Enrolling, Phase III
Updated: 12/31/1969
MD Anderson Cancer Center at Katy
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Local Consolidation Therapy (LCT) After Nivolumab and Ipilimumab (LONESTAR)
Status: Enrolling, Phase III
Updated: 12/31/1969
MD Anderson Cancer Center Bay Area
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
SQUAMOUS CELL CARCINOMA Clinical Trial
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Chan Soon-Shiong Institute for Medicine
mi
from
El Segundo, CA
Click here to add this to my saved trials
Neoplasms Clinical Trial
Clinical Evaluation of a New Form of Cancer Therapy Based on the Principles of Atavistic Metamorphosis (Atavistic Chemotherapy).
Status: Enrolling, Phase II
Updated: 2/10/2018
Dr. Frank Arguello Cancer Clinic
mi
from
San Jose del Cabo,
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150]
Status: Enrolling, Phase III
Updated: 12/31/1969
M.D Anderson Cancer Center; Uni of Texas At Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150]
Status: Enrolling, Phase III
Updated: 12/31/1969
Uni of California - San Diego; Cancer Center & Dept of Medicine
mi
from
La Jolla, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of AG-270 in Subjects With Advanced Solid Tumors or Lymphoma With MTAP Loss
Status: Enrolling, Phase I
Updated: 12/31/1969
Investigator Site - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of AG-270 in Subjects With Advanced Solid Tumors or Lymphoma With MTAP Loss
Status: Enrolling, Phase I
Updated: 12/31/1969
Investigator Site - Nashville
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of NKTR-262 in Combination With NKTR-214 and With NKTR-214 Plus Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of NKTR-262 in Combination With NKTR-214 and With NKTR-214 Plus Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - New Haven
mi
from
New Haven, CT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Facilitating Oncology Patient-Clinician Communication Via E-health Innovations
Status: Enrolling
Updated: 12/31/1969
University of Nebraska Medical Center Oncology Clinics
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Cardiac MRI Biomarker Testing (GCC 1618)
Status: Enrolling, Phase
Updated: 3/27/2018
Ummc Msgccc
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
[Site 12] University of Texas M.D. Anderson Cancer Center - Investigational Cancer Therapeutics
mi
from
Houston, TX
Click here to add this to my saved trials